Jasper Therapeutics, Inc. - Voting Common Stock (JSPR)

CUSIP: 471871202

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
+1,599,050
Put/Call ratio
23%
SEC-reported price per share
$22.70
Number of holders
67
Value change
+$34,893,415
Number of buys
41
Open additional details 1 more signal available
Number of sells
27
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,779,583

Security key

471871202

Report period

Q2 2024

Institutions

67

Top holders

10

Ownership snapshot

Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Velan Capital Investment ...
Disclosed value leader
Velan Capital Investment ...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F 3/4/5 Lead comparable stake: 5.3% Showing 1-6 of 15 holder rows.

Quick read

Velan Capital Investment Management LP leads the comparable SEC ownership view at 5.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Velan Capital Investment Management LP's linked filing trail.
Comparable ownership Top 5
Velan Capital Investment Manageme... 5.3%
Soleus Capital Management, L.P. 4.3%
Carlyle Group Inc. 3.8%
Qiming U.S. Ventures Management, LLC 3.3%
Avidity Partners Management LP 2.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Velan Capital Investment Management LP
13F 3/4/5
Company · 10%+ Owner
5.3%
$42,097,193
1,471,904 shares
31 Mar 2024
Soleus Capital Management, L.P.
13F
Company
13F
4.3%
$34,853,139
1,187,096 shares
31 Mar 2024
Carlyle Group Inc.
13F 3/4/5
Company · Former 10% Owner
3.8%
$31,303,309
1,066,189 shares
31 Mar 2024
Qiming U.S. Ventures Management, LLC
13F
Company
13F
3.3%
$27,274,383
928,964 shares
31 Mar 2024
Avidity Partners Management LP
13F
Company
13F
2.7%
$22,313,600
760,000 shares
31 Mar 2024
FRANKLIN RESOURCES INC
13F
Company
13F
2.6%
$21,200,093
722,074 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
67
Shares
14,557,013
Rows available
67
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
56
Q2 2024 holders
67
Holder diff
11
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .